2.69
Savara Inc Aktie (SVRA) Neueste Nachrichten
Savara Inc. Awards Stock Options and RSUs to New Employees - MSN
SVRASavara Inc Latest Stock News & Market Updates - StockTitan
Savara Announces New Employment Inducement Grant - Milton Daily Standard
Savara's Latest Executive Compensation Package Revealed: Key Details on New Employee Stock Awards - StockTitan
A company insider recently sold 25,000 shares of Savara Inc [SVRA]. Should You Sale? - Knox Daily
SG Americas Securities LLC Has $158,000 Holdings in Savara Inc (NASDAQ:SVRA) - Defense World
SVRA’s latest rating updates from top analysts. - Knox Daily
Positive Signs As Multiple Insiders Buy Savara Stock - Yahoo Finance UK
Investing in Savara Inc (SVRA) Is Getting More Attractive - Knox Daily
Savara Inc. to Present at Upcoming Healthcare Investor Conferences - MSN
Savara Inc. Publishes Promising Long-Term Outcomes for aPAP Treatment - MSN
Analysts Predict How High Savara Inc (SVRA) Will Go. - Stocks Register
JPMorgan Chase & Co. Purchases 13,420 Shares of Savara Inc (NASDAQ:SVRA) - Defense World
Molgramostim shows promise in rare lung disease treatment - MSN
SVRA stock touches 52-week low at $2.6 amid market challenges - MSN
Savara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open Research - Business Wire
Savara Announces Participation in Upcoming Healthcare Investor Conferences - The Bakersfield Californian
Savara Inc (NASDAQ:SVRA) Receives $9.86 Average PT from Brokerages - Defense World
Savara Inc (NASDAQ:SVRA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Title: Savara Inc. Approves 2025 Executive Officers’ Target Bonus Amounts - Defense World
Savara sets executive bonus targets for 2025 - MSN
Savara sets executive bonus targets for 2025 By Investing.com - Investing.com Australia
Savara Sets 2025 Executive Bonus Targets - TipRanks
Savara Inc Updates Corporate Presentation in Latest SEC Filing - Defense World
Savara (NASDAQ:SVRA) Stock Price Down 5.3%Here's What Happened - MarketBeat
Savara Inc. Launches Early Access Program for Rare Lung Disease Treatment - MSN
Savara Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference - MSN
Savara (NASDAQ:SVRA) Shares Up 8.1%Should You Buy? - MarketBeat
Barclays PLC Buys 158,244 Shares of Savara Inc (NASDAQ:SVRA) - Defense World
Savara Highlights MOLBREEVI’s Potential in Rare Disease Market - TipRanks
Institutional investors may adopt severe steps after Savara Inc.'s (NASDAQ:SVRA) latest 11% drop adds to a year losses - Simply Wall St
Savara Inc (NASDAQ:SVRA) Shares Sold by Jane Street Group LLC - Defense World
SVRA Stock Touches 52-Week Low at $2.81 Amid Market Challenges By Investing.com - Investing.com South Africa
SVRA Stock Touches 52-Week Low at $2.81 Amid Market Challenges - Investing.com Australia
Savara Inc. Grants Inducement Awards to New Employees - MSN
Principal Financial Group Inc. Sells 7,607 Shares of Savara Inc (NASDAQ:SVRA) - Defense World
Savara Inc (NASDAQ:SVRA) Receives $9.86 Average Price Target from Brokerages - Defense World
Savara Inc (NASDAQ:SVRA) Receives $9.86 Consensus Target Price from Analysts - MarketBeat
Geode Capital Management LLC Raises Stock Holdings in Savara Inc (NASDAQ:SVRA) - Defense World
Geode Capital Management LLC Buys 264,825 Shares of Savara Inc (NASDAQ:SVRA) - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):